Terlipressin and albumin for type 1 hepatorenal syndrome: does bacterial infection affect the response?

Vasoconstrictor therapy with terlipressin and concomitant albumin can improve renal function in patients with hepatorenal syndrome (HRS) type 1, but the efficacy of therapy in patients with active infection is controversial. The aim of this study was to investigate the efficacy, adverse effects, and...

Descripción completa

Detalles Bibliográficos
Autores principales: Altun, Reskan, Korkmaz, Murat, Yıldırım, Emre, Öcal, Serkan, Akbaş, Enver, Selçuk, Haldun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689717/
https://www.ncbi.nlm.nih.gov/pubmed/26722626
http://dx.doi.org/10.1186/s40064-015-1625-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4689717/
https://www.ncbi.nlm.nih.gov/pubmed/26722626
http://dx.doi.org/10.1186/s40064-015-1625-z

Ejemplares similares